Effect of Intravenous Dexmedetomidine Versus Dexamethasone for Management of Repound Pain After Supraclavicular Brachial Plexus Block

Launched by ASSIUT UNIVERSITY · Mar 8, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how two different medications, dexmedetomidine and dexamethasone, can help manage pain after a specific type of nerve block called a supraclavicular brachial plexus block, which is often used for surgeries on the arm. The goal is to see which medication is more effective in reducing pain that can occur after the procedure.

To participate in this trial, individuals need to be between 20 and 60 years old and be scheduled for surgery that involves a nerve block. They should also be in good overall health, specifically classified as ASA status I or II, which means they have a low risk of complications. However, people who have certain medical conditions or allergies that could complicate their participation will not be eligible. This trial is currently not recruiting participants, but it aims to provide valuable information on pain management options for patients undergoing upper extremity surgeries.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients between 20_60 years old
• • Patients with ASA clinical status I/II
• • Patients scheduled for peripheral nerve block for upper extremity surgery
• Exclusion Criteria:
• • 1) they refused to participate 2) had preexisting neuropathy of the surgical limb 3) hypersensitivity to amide anesthetic 4) significant pulmonary disease 5) coagulopathy 6) sepsis 7) infection at the block site 8) hypersensitivity to dexmedetomidine \& dexamethasone